Models for accessing biomedical innovation in Asia

摘要: Asian countries are striving to transition into innovation driven economies, and healthcare is a key sector on government agendas. Strong funding at academic institutions, high impact publications, state-of-the-art clinical infrastructure, vast talent pool, increasing start-up activity strengthening intellectual property regime, all aligned with coherent policies, creating an evolving ecosystem in such as China, South Korea, Singapore, Taiwan India. Such factors have fuelled desire from global pharmaceutical companies seek Asia. In this article, we reviewed the varied strategies of large multinationals using two aspects – capital investments operational model understand diverse approaches.  Based qualitative quantitative analysis, classified these four distinct approaches “ Captive ”, Partner Service ” Open models discussed case studies that fit each clusters. The may provide framework evaluate their respective for sourcing align them operational, financial, business strategic needs organizations